Literature DB >> 29382993

Comparative Evaluation of the Intranasal Spray Formulation of Midazolam and Dexmedetomidine in Patients Undergoing Surgical Removal of Impacted Mandibular Third Molars: A Split Mouth Prospective Study.

Shashank Hiwarkar1, Rajesh Kshirsagar1, Vikram Singh1, Amod Patankar1, Sanjay Chandan1, Mukund Rathod1, Ajay Mohite1.   

Abstract

PURPOSE: The purpose of this prospective randomized single blinded split mouth study was to conduct a comparative evaluation of the efficacy of intranasal atomised spray formulation of Dexmedetomidine with Midazolam in patients undergoing surgical removal of bilaterally impacted mandibular third molars.
METHODS: This prospective study was conducted in twenty volunteers. Each volunteer underwent the surgical removal of an impacted mandibular third molar at two separate appointments at an interval of two weeks. The first third molar surgery was conducted using either intranasal Midazolam (Group M) or intranasal Dexmedetomidine (Group D). At the second appointment the surgical procedure was performed using the sedative agent not used at the first appointment. The primary testing outcome variables were Plasma oxygen saturation (SpO2), pulse and blood pressure and Modified Observer's Assessment of Alertness/Sedation (OAA/S) scale. These were recorded at predetermined intervals starting 10 min before the administration of local anaesthesia and continued up to 10 min after completion of the procedure. In addition surgeon's opinion regarding the patient cooperation, event amnesia, post operative nausea & vomiting were obtained.
RESULTS: The sample composed of twenty patients (M = 9 and F = 11). There was statistically no significant difference between Group M and Group D with respect to mean SpO2. Minor differences were however noted at 20 and 30 min after sedation. There was no significant difference between the groups with respect to mean pulse rate, blood pressure, OAA/S, event amnesia, post operative nausea and vomiting and patient cooperation.
CONCLUSION: We conclude that Midazolam and Dexmedetomidine are equivalent and can be used in minor oral surgery with minimal complications. These drugs can be used intranasally using nasal atomization device in routine outpatient basis in otherwise normal healthy but anxious patients. All procedures must however be performed in the presence of an anaesthesiologist and with ready availability of emergency drugs and equipment.

Entities:  

Keywords:  Dexmedetomidine; Intranasal spray formulation; Midazolam; Nasal atomization device

Year:  2016        PMID: 29382993      PMCID: PMC5772022          DOI: 10.1007/s12663-016-0992-5

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  28 in total

1.  Intranasal midazolam as an alternative to general anaesthesia in the management of children with oral and maxillofacial trauma.

Authors:  C J Lloyd; T Alredy; J C Lowry
Journal:  Br J Oral Maxillofac Surg       Date:  2000-12       Impact factor: 1.651

2.  Intranasal midazolam as a sedative for children during laceration repair.

Authors:  D M Yealy; J H Ellis; G D Hobbs; R M Moscati
Journal:  Am J Emerg Med       Date:  1992-11       Impact factor: 2.469

3.  Dexmedetomidine versus midazolam in outpatient third molar surgery.

Authors:  Yakup Ustün; Murat Gündüz; Ozgür Erdoğan; M Emre Benlidayi
Journal:  J Oral Maxillofac Surg       Date:  2006-09       Impact factor: 1.895

4.  A comparison of midazolam and midazolam with remifentanil for patient-controlled sedation during operations on third molars.

Authors:  Hasan Garip; Yavuz Gürkan; Kamil Toker; Kamil Göker
Journal:  Br J Oral Maxillofac Surg       Date:  2006-08-23       Impact factor: 1.651

5.  Intranasal midazolam for premedication of children undergoing day-case anaesthesia: comparison of two delivery systems with assessment of intra-observer variability.

Authors:  N Griffith; S Howell; D G Mason
Journal:  Br J Anaesth       Date:  1998-12       Impact factor: 9.166

6.  Prolonged recovery associated with dexmedetomidine when used as a sole sedative agent in office-based oral and maxillofacial surgery procedures.

Authors:  Laila Makary; Vadim Vornik; Richard Finn; Fima Lenkovsky; Allan L McClelland; Jeremy Thurmon; Brian Robertson
Journal:  J Oral Maxillofac Surg       Date:  2010-02       Impact factor: 1.895

7.  Oral midazolam for sedation in minor oral operations in children: a retrospective study.

Authors:  Atsushi Kohjitani; Hitoshi Higuchi; Masahiko Shimada; Takuya Miyawaki
Journal:  Br J Oral Maxillofac Surg       Date:  2007-09-07       Impact factor: 1.651

8.  A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation.

Authors:  Daniel P Wermeling; Kenneth A Record; Sanford M Archer; Anita C Rudy
Journal:  Epilepsy Res       Date:  2008-11-29       Impact factor: 3.045

9.  Complications of sevoflurane-fentanyl versus midazolam-fentanyl anesthesia in pediatric cleft lip and palate surgery: a randomized comparison study.

Authors:  M Milić; T Goranović; P Knezević
Journal:  Int J Oral Maxillofac Surg       Date:  2009-10-24       Impact factor: 2.789

10.  Effects of low-dose midazolam with propofol in patient-controlled sedation (PCS) for apicectomy.

Authors:  Zuhal Küçükyavuz; Mine Cambazoğlu
Journal:  Br J Oral Maxillofac Surg       Date:  2004-06       Impact factor: 1.651

View more
  1 in total

1.  Comparison of dexmedetomidine with midazolam for dental surgery: A systematic review and meta-analysis.

Authors:  Yibo Zhang; Chao Li; Jingjing Shi; Yanming Gong; Tao Zeng; Min Lin; Xi Zhang
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.